Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Avg
|
|
New words:
adversarial, Angioblast, announced, arm, ASU, authoritative, Biosurgery, boundary, Cardiology, carryover, cautioned, children, clarifying, collaterialized, comment, correspondingly, counsel, crossed, CRP, deliverable, disaggregation, dividend, entry, fatal, flaw, freely, Freidli, futility, goal, half, hierarchy, inclusion, insignificant, IP, LLP, navigate, Notwithstanding, outplacement, protein, Reform, residual, retired, reveal, sickest, standalone, subset, Subtopic, theJournal, Thornton, thousand, Topic, tradable, uncollectible, unmatched, unresponsive, unused, unutilized, vendor, workforce, YearsMichelle, yield
Removed:
accredited, advice, AG, APB, auction, Blackstone, Bulletin, caption, Carmitchel, Centigrade, compassionate, computation, consisting, consummated, consummation, contemplated, deducting, deployed, destroying, earlier, effected, exemption, fact, forma, Fourteen, Harry, hospital, IRC, kilogram, largest, liaison, living, manager, Mandatorily, McQuay, measuring, notify, overcome, overnight, Pacific, Pharmacopeia, pro, reclassified, Redeemable, referral, register, registration, retrospective, retrospectively, reverse, revision, running, send, senior, serological, serum, spent, split, Stryker, suppressing, team, thereto, unvested, vested, weight
Filing tables
Filing exhibits
Related press release
Osiris Therapeutics similar filings
Filing view
External links
QuickLinks -- Click here to rapidly navigate through this document
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We have issued our report dated March 12, 2010, with respect to the financial statements and internal control over financial reporting included in the Annual Report of Osiris Therapeutics, Inc. on Form 10-K for the year ended December 31, 2009. We hereby consent to the incorporation by reference of said report in the Registration Statements of Osiris Therapeutics, Inc. on Form S-8 (Nos. 333-137952 and 333-137953) and on Form S-3 (No. 333-148750).
/s/GRANT THORNTON LLP
Baltimore, Maryland
March 12, 2010
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM